The bionic devices market size is expected to see strong growth in the next few years. It will grow to $8.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising demand for highly responsive and lifelike prosthetic movement, increasing investment in neural interface and brain-machine control research, wider adoption of bionic devices in rehabilitation medicine, growing focus on quality of life improvement and mobility independence, expansion of customized and patient-specific bionic device development. Major trends in the forecast period include increasing integration of sensor-based and neural-controlled prosthetic systems, rising adoption of advanced bionic limbs for enhanced mobility and dexterity, growing use of myoelectric and actuator-driven assistive devices, expansion of bionic solutions for organ support and functional restoration, focus on patient-centric design, comfort, and realistic movement performance.
The increasing demand for joint replacements is expected to drive growth in the bionic devices market. Joint replacements involve surgical procedures where damaged or diseased joints are replaced with artificial implants to restore function and alleviate pain. This trend is growing due to an aging population, a rising prevalence of osteoarthritis, and advancements in surgical techniques and implant materials. Bionic devices for joint replacement improve mobility and functionality, reduce pain, and provide customized, durable solutions with advanced technology integration. For example, in April 2023, the National Institutes of Health reported a 14% increase in registered hip and knee procedures in 2022, based on data from over 2.8 million procedures across more than 1,250 institutions. Thus, the rising demand for joint replacements is driving the growth of the bionic devices market.
Major companies operating in the bionic devices market are increasingly prioritizing neuro-driven interfaces, such as minimally invasive neural control systems for prosthetic limbs, to achieve more intuitive, accurate movement control while minimizing surgical risk. These systems translate electrical signals from residual nerves or muscles into precise prosthetic commands, significantly improving user functionality and rehabilitation outcomes. For instance, in April 2025, Ottobock, a Germany-based prosthetics company, led a US$19 million Series A funding round for Phantom Neuro, a US-based neurotechnology firm, to accelerate development of its Phantom X interface. Phantom X is an implantable muscle-machine interface placed beneath the skin that reads electrical impulses from residual nerves and converts them into control signals for prosthetic limbs or exoskeletons. The system demonstrates 94% decoding accuracy across 11 distinct hand and wrist movements, features a thin strip-style implant that is less invasive than traditional brain implants, and supports rapid calibration - enabling users to regain up to 85% functional control after just 10 minutes of calibration.
In February 2024, Hanger Inc., a US-based provider of orthotic and prosthetic (O&P) patient care services and products, acquired Fillauer Companies Inc. for an undisclosed amount. This acquisition allows Hanger Inc. to expand its portfolio of advanced prosthetic and orthotic products, enhance its technological capabilities, and extend its market reach to better serve patients with innovative mobility solutions. Fillauer Companies Inc., a US-based company specializing in orthotic and prosthetic products and services, offers bionic devices.
Major companies operating in the bionic devices market are Ottobock SE and Co. KGaA, Hanger Inc., Cochlear Limited, Ossur hf., Bionx Medical Technologies Inc., Berlin Heart GmbH, Cyberdyne Inc., Ekso Bionics Holdings Inc., Open Bionics Ltd., Jarvik Heart Inc., Axosuits Srl, Bioservo Technologies AB, Carmat SA, ActiveLink Inc., ReWalk Robotics Ltd., B-Temia Inc., Bionik Laboratories Corp., COAPT LLC, Pixium Vision SA, Mobius Bionics LLC, Nano Retina Inc.
North America was the largest region in the bionic devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bionic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bionic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bionic devices market by increasing the cost of actuators, sensor modules, semiconductor chips, lightweight alloys, and electronic control systems sourced through global supply chains, resulting in higher manufacturing and integration expenses. The effect is particularly significant for advanced robotic prosthetics and neural-interface-enabled devices produced in Asia-Pacific and European engineering hubs that depend on imported precision components. Hospitals, rehabilitation centers, and specialty prosthetic clinics are experiencing procurement delays and increased pricing as tariff-related costs are passed through to end users. However, tariffs are also encouraging localized assembly, domestic component sourcing, and regional innovation partnerships, which may strengthen long-term supply resilience and stimulate local manufacturing ecosystems.
The bionic devices market research report is one of a series of new reports that provides bionic devices market statistics, including bionic devices industry global market size, regional shares, competitors with a bionic devices market share, detailed bionic devices market segments, market trends and opportunities, and any further data you may need to thrive in the bionic devices industry. This bionic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bionic devices are advanced prosthetic systems that combine mechanical elements with electronic components to replicate the functionality of natural limbs or organs. These devices often include sensors, actuators, and sometimes neural interfaces to enhance control and mimic natural movement or biological processes. Their goal is to restore or augment human capabilities, thereby improving the quality of life for individuals with disabilities.
The primary categories of bionic devices include vision bionics, ear bionics, orthopedic bionics, and cardiac bionics. Vision bionics are designed to restore or enhance vision for individuals with visual impairments. These devices can be made from various materials such as tungsten, silicon, platinum-iridium, stainless steel, and biologics, and can be implemented in different forms, including implantable, wearable, and externally worn types. They also utilize various technologies, including electronics and mechanical systems, and are used by a range of end users, such as hospitals, clinics, research and academic institutes, and other organizations.
The bionic devices market consists of sales of bionic implants, exoskeletons, cochlear implants, and functional electrical stimulation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Bionic Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bionic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bionic devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bionic devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Upper-Limb Prosthetics; Lower-Limb Prosthetics; Exoskeletons; Bionic Organs; Soft Robotics & Assistive Devices2) By Technology: Sensor-Based Devices; Actuator-Based Devices; Neural-Controlled Interfaces; Hybrid Systems
3) By Application: Rehabilitation; Daily Assistance; Military/Industrial; Medical Enhancement
4) By End User: Individuals with Disabilities; Hospitals and Rehabilitation Centers; Research & Clinical Institutions; Specialized Clinics
Subsegments:
1) By Upper-Limb Prosthetics: Myoelectric Hands; Robotic Arms; Partial Finger Prosthetics2) By Lower-Limb Prosthetics: Robotic Legs & Feet; Knee Prosthetics; Ankle-Foot Prosthetics
3) By Exoskeletons: Rehabilitation Exoskeletons; Industrial/Load-Bearing Exoskeletons; Military/Defense Exoskeletons
4) By Bionic Organs: Artificial Heart Systems; Cochlear Implants; Retinal Implants
5) By Soft Robotics & Assistive Devices: Soft Robotic Gloves; Wearable Support Devices; Assistive Devices for Fine Motor Skills
Companies Mentioned: Ottobock SE and Co. KGaA; Hanger Inc.; Cochlear Limited; Ossur hf.; Bionx Medical Technologies Inc.; Berlin Heart GmbH; Cyberdyne Inc.; Ekso Bionics Holdings Inc.; Open Bionics Ltd.; Jarvik Heart Inc.; Axosuits Srl; Bioservo Technologies AB; Carmat SA; ActiveLink Inc.; ReWalk Robotics Ltd.; B-Temia Inc.; Bionik Laboratories Corp.; COAPT LLC; Pixium Vision SA; Mobius Bionics LLC; Nano Retina Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bionic Devices market report include:- Ottobock SE and Co. KGaA
- Hanger Inc.
- Cochlear Limited
- Ossur hf.
- Bionx Medical Technologies Inc.
- Berlin Heart GmbH
- Cyberdyne Inc.
- Ekso Bionics Holdings Inc.
- Open Bionics Ltd.
- Jarvik Heart Inc.
- Axosuits Srl
- Bioservo Technologies AB
- Carmat SA
- ActiveLink Inc.
- ReWalk Robotics Ltd.
- B-Temia Inc.
- Bionik Laboratories Corp.
- COAPT LLC
- Pixium Vision SA
- Mobius Bionics LLC
- Nano Retina Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.37 Billion |
| Forecasted Market Value ( USD | $ 8.76 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |


